Stockreport

Generation Bio Announces Recent Business Highlights and First Quarter 2024 Financial Results

Generation Bio Co. - Common stock  (GBIO) 
PDF - Oral presentation at ASGCT described selective, high levels of therapeutic transgene delivery to T cells in vivo by cell-targeted lipid nanoparticle (ctLNP) - ASGCT p [Read more]